Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for System Suitability Testing in HPLC – V 2.0

Posted on By

API Manufacturing: SOP for System Suitability Testing in HPLC – V 2.0

Standard Operating Procedure for System Suitability Testing in HPLC for API Manufacturing

Department API Manufacturing
SOP No. SOP/API/124/2025
Supersedes SOP/API/124/2022
Page No. Page 1 of 8
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standard procedure for performing system suitability testing (SST) in HPLC analysis before initiating sample analysis of API raw materials, intermediates, or finished products to verify the performance of the chromatographic system.

2. Scope

This SOP applies to all QC analysts and instruments used for HPLC-based analysis in the Quality Control (QC) laboratory involved

in the testing of APIs at various manufacturing stages.

3. Responsibilities

  • QC Analyst: Perform SST as per method and document results in SST logbook.
  • QC Reviewer: Verify system suitability parameters before approving batch analysis.
  • QA Officer: Audit SST compliance during data review and batch release.
See also  API Manufacturing: SOP for In-Process Sampling Technique - V 2.0

4. Accountability

The Head – QC is accountable for ensuring that no analysis is initiated unless the HPLC system meets the system suitability criteria as per approved analytical method or pharmacopeial monograph.

5. Procedure

5.1 General Guidelines

  1. System suitability must be run at the start of each sequence or analysis session.
  2. Prepare the system suitability solution or standard as per the method (STP or pharmacopoeia).
  3. Ensure column, detector, pump, and autosampler are stabilized.

5.2 SST Parameters

  1. System suitability parameters include but are not limited to:
    • Retention time (Rt): Must be consistent (±2%)
    • Theoretical plates (N): Indicates column efficiency
    • Tailing factor (T): Should be ≤2.0 unless specified
    • Resolution (Rs): Between critical peaks must be ≥2.0
    • % RSD: For replicate injections should be within acceptance criteria (usually NMT 2.0%)
See also  API Manufacturing: SOP for Cleaning of Manufacturing Equipment - V 2.0

5.3 SST Execution

  1. Inject the standard solution as per method (minimum 5 injections unless specified).
  2. Record the chromatographic data and calculate system suitability parameters.
  3. Compare the observed values with the criteria defined in the STP or monograph.
  4. Document results in the SST Record Sheet (Annexure-1).

5.4 Acceptance and Continuation

  1. If SST passes:
    • Proceed with sample analysis.
    • Ensure no major instrument changes are made post-SST.
  2. If SST fails:
    • Do not proceed with sample analysis.
    • Investigate cause (e.g., column issue, mobile phase prep, instrument error).
    • Rectify and re-perform SST.

5.5 Frequency

  1. Perform SST:
    • Before each analytical run
    • After major instrument maintenance
    • After column change or mobile phase change

6. Abbreviations

  • HPLC: High-Performance Liquid Chromatography
  • SST: System Suitability Testing
  • Rt: Retention Time
  • N: Number of Theoretical Plates
  • Rs: Resolution
  • RSD: Relative Standard Deviation
  • QA: Quality Assurance
  • QC: Quality Control
See also  API Manufacturing: SOP for Use of Handheld pH/Conductivity Meters - V 2.0

7. Documents

  1. System Suitability Test Record Sheet (Annexure-1)
  2. Instrument Usage Logbook
  3. Analytical Method or STP

8. References

  • USP <621> – Chromatography
  • ICH Q2 (R1) – Validation of Analytical Procedures
  • 21 CFR Part 211 – US FDA GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: System Suitability Test Record Sheet

Date Instrument ID Column ID Parameter Observed Value Limit Pass/Fail
13/04/2025 HPLC-02 C18-0923 %RSD 1.2% NMT 2.0% Pass
13/04/2025 HPLC-02 C18-0923 Resolution 3.2 NLT 2.0 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
13/04/2025 2.0 Added specific SST parameters and log format Audit Feedback QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: HPLC Method Development for API – V 2.0
Next Post: Creams: SOP for Analyzing Preservative Levels in Creams – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version